COSM vs. BIMI, MEDS, GHSI, TRIB, AIKI, PSTV, AVTX, MBRX, IKT, and ONMD
Should you be buying Cosmos Health stock or one of its competitors? The main competitors of Cosmos Health include BIMI (BIMI), TRxADE HEALTH (MEDS), Guardion Health Sciences (GHSI), Trinity Biotech (TRIB), AIkido Pharma (AIKI), Plus Therapeutics (PSTV), Avalo Therapeutics (AVTX), Moleculin Biotech (MBRX), Inhibikase Therapeutics (IKT), and OneMedNet (ONMD). These companies are all part of the "medical" sector.
BIMI (NASDAQ:BIMI) and Cosmos Health (NASDAQ:COSM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking.
Cosmos Health has a net margin of -31.48% compared to Cosmos Health's net margin of -94.58%. BIMI's return on equity of -28.54% beat Cosmos Health's return on equity.
In the previous week, Cosmos Health had 12 more articles in the media than BIMI. MarketBeat recorded 16 mentions for Cosmos Health and 4 mentions for BIMI. Cosmos Health's average media sentiment score of 0.93 beat BIMI's score of 0.24 indicating that BIMI is being referred to more favorably in the media.
BIMI received 5 more outperform votes than Cosmos Health when rated by MarketBeat users. However, 70.69% of users gave Cosmos Health an outperform vote while only 57.50% of users gave BIMI an outperform vote.
0.1% of BIMI shares are held by institutional investors. Comparatively, 12.6% of Cosmos Health shares are held by institutional investors. 69.0% of BIMI shares are held by insiders. Comparatively, 18.7% of Cosmos Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
BIMI has a beta of 1.72, suggesting that its share price is 72% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 5.84, suggesting that its share price is 484% more volatile than the S&P 500.
Cosmos Health has higher revenue and earnings than BIMI.
Summary
Cosmos Health beats BIMI on 10 of the 14 factors compared between the two stocks.
Get Cosmos Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for COSM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COSM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Cosmos Health Competitors List
Related Companies and Tools